Please join the Healthcare and Insurance Committee for a lively and informative lunch event on the new and upcoming area of Personalized or Precision Medicine.
In tailoring medical decisions, interventions and products to people based on their predicted responses there are many factors to consider including availability and delivery of testing, treatments, healthcare professionals as well as affordability and infrastructure.
With the scientific advances that are taking place, including the study of genomics which enable new approaches to diagnosis, drug development and tailored treatment, how can we ensure Hong Kong remains at the forefront?
A brief rundown is as follows:
- Presentation from HKAPI Research and Development Ecosystem Taskforce:
Sabrina Chan, Senior Executive Director, HKAPI
Lawrence Wong, Research and Development Ecosystem Taskforce Sponsor, HKAPI and General Manager, Ferring
- Panel Discussion:
Dr. York Yat-Ngok Chow, Chief Medical Officer and Corporate Advisor, AIA Hong Kong and Macau Ltd.
Dr. Angus KC Leung, Specialist in Clinical Oncology, Amo Oncology Centre
Dr. Daniel Thurley, Research and Development Ecosystem Taskforce Sponsor , HKAPI and General Manager, Roche
First 15-20 minutes is for networking
Sandwiches and beverages included
Hosted by the Healthcare and Insurance Committee